Creative Planning’s Acura Pharmaceuticals ACUR Stock Holding History

Creative Planning’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-145	Closed	–	–	5127
2016 Q4	$0	Hold	145	–	–	﹤0.01%	5041
2016 Q3	$0	Buy	145 +45	+45%	+$80	﹤0.01%	4874
2016 Q2	$0	Hold	100	–	–	﹤0.01%	4667
2016 Q1	$0	Hold	100	–	–	﹤0.01%	4718
2015 Q4	$0	Buy	+100	New	+$243	﹤0.01%	4747
2015 Q1	–	Sell	-13,289	Closed	-$30K	–	4542
2014 Q4	$30K	Sell	13,289 -4,680	-26%	-$12.9K	﹤0.01%	2364
2014 Q3	$70K	Sell	17,969 -3,111	-15%	-$14.6K	﹤0.01%	1707
2014 Q2	$115K	Buy	+21,080	New	+$128K	﹤0.01%	1357

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Creative Planning's ACUR Position: Q1 2017 in Review

Creative Planning sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 145 shares.

Creative Planning first reported a position in ACUR in Q2 2014 and held it in 8 quarters. The position peaked at $115K in Q2 2014. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

Creative Planning reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Creative Planning sold 145 Acura Pharmaceuticals shares in Q1 2017.
Creative Planning first reported a position in Acura Pharmaceuticals in Q2 2014 and held it in 8 quarters.
Creative Planning's Acura Pharmaceuticals position peaked at $115K in Q2 2014.
3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Creative Planning's 13F filing for Q1 2017, filed 7 Apr 2017.